Anna Berkenblit
2018
In 2018, Anna Berkenblit earned a total compensation of $1.8M as Senior Vice President and Chief Medical Officer at ImmunoGen, a 81% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $167,506 |
|---|---|
| Option Awards | $1,202,454 |
| Salary | $430,654 |
| Other | $8,880 |
| Total | $1,809,494 |
Berkenblit received $1.2M in option awards, accounting for 66% of the total pay in 2018.
Berkenblit also received $167.5K in non-equity incentive plan, $430.7K in salary and $8.9K in other compensation.
Rankings
In 2018, Anna Berkenblit's compensation ranked 6,237th out of 14,244 executives tracked by ExecPay. In other words, Berkenblit earned more than 56.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 6,237 out of 14,244 | 56th |
Division Manufacturing | 2,388 out of 5,765 | 59th |
Major group Chemicals And Allied Products | 892 out of 2,128 | 58th |
Industry group Drugs | 748 out of 1,817 | 59th |
Industry Pharmaceutical Preparations | 581 out of 1,391 | 58th |
Source: SEC filing on April 28, 2020.
Berkenblit's colleagues
We found five more compensation records of executives who worked with Anna Berkenblit at ImmunoGen in 2018.
2018
Mark Enyedy
ImmunoGen
Chief Executive Officer
2018
Richard Gregory
ImmunoGen
Chief Scientific Officer
2018
Craig Barrows
ImmunoGen
General Counsel
2018
Theresa Wingrove
ImmunoGen
Senior Vice President, Regulatory Affairs and Quality
2018
Thomas Ryll
ImmunoGen